STAT3 and chronic myelogenous leukemia, BCR-ABL1 positive: Moreover, using a CML multidrug resistance (MDR)/Imatinib resistant cell line (Lucena) and CML patients’ samples we address the relationship of STATIP1 and STAT3 in IM resistance.